RELB and prostate carcinoma: For example, EZH2 forms a complex with RelA and RelB to activate nuclear factor κB signaling in estrogen receptor-negative breast cancer cells52 and activates androgen receptor gene transcription through binding at the androgen receptor promoter in prostate cancer cells53,54.